Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs Remimazolam for Sedation in Fiberoptic Bronchoscopy
NCT06531915Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Dec 2024
- Primary completion
- Dec 2024
- Modality
- Allosteric Modulators
01
Overview
Randomised, double-blind trial of ciprofol in Procedural sedation (PS) (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Success rate of fiberoptic bronchoscopy at 24 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT06531915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06531915.